Table 5.
Oxidative stress markers.
| Reference | Sample Size | Acute Response on Oxidative Stress and Antioxidant Status | |||||||
|---|---|---|---|---|---|---|---|---|---|
| MDA | TBARS | OS | TAC | CAT | SOD | GPX | GSH | ||
| Ammar et al., 2020 [35] (anerobic) | 10 | sig ↑ | - | - | ns ↑ | - | sig ↑ * | sig ↑ * | - |
| Ammar et al., 2020 [35] (combined) | 10 | ns ↑ | - | - | ns ↑ | - | sig ↑ * | sig ↑ * | - |
| Baker et al., 2004 [36] (TBM) | 18 | sig ↑ * | - | - | - | - | - | - | - |
| Baker et al., 2004 [36] (FFM) | 18 | ns ↑ * | - | - | - | - | - | - | - |
| Berzosa er al., 2011 [37] (incremental) | 34 | - | - | - | sig ↑ | sig ↑ | ns ↑ | sig ↑ | - |
| Berzosa er al., 2011 [37] (all-out) | 34 | - | - | - | sig ↑ | sig ↑ | sig ↑ | sig ↑ | - |
| Berzosa er al., 2011 [37] (70% VO2max) | 34 | - | - | - | sig ↑ | sig ↑ | sig ↑ | sig ↑ | - |
| Bogdanis et al., 2013 [38] (pre-training) | 8 | - | sig ↑ | - | sig ↑ | sig ↑ | - | ns ↑ | - |
| Bogdanis et al., 2013 [38] (post-training) | 8 | - | sig ↑ | - | ns ↑ | sig ↑ | - | ns ↑ | - |
| Bouzid et al., 2014 [39] (young) | 15 | ns ↑ * | - | - | - | - | sig ↑ * | sig ↑ | - |
| Bouzid et al., 2014 [39] (old) | 15 | sig ↑ * | - | - | - | - | ns ↑ * | ns ↑ | - |
| Djordjevic et al., 2012 [40] (athletes) | 58 | - | ns ↑ | - | - | sig ↓ | ns ↓ | - | ns ↑ |
| Djordjevic et al., 2012 [40] (non-athletes) | 37 | - | sig ↓ | - | - | ns | ns ↑ | - | ns ↑ |
| Falone et al., 2010 [41] (amateur runner) | 33 | ns ↓ * | - | - | ns * | - | - | - | - |
| Falone et al., 2010 [41] (untrained) | 25 | ns ↑ * | - | - | sig ↓ * | - | - | - | - |
| Finkler et al., 2016 [42] | 32 | - | sig ↑ | - | - | sig ↑ | - | ns ↑ | - |
| Fisher et al., 2011 [43] (first) | 8 | sig ↑ | sig ↑ | - | - | sig ↑ | sig ↑ | sig ↑ | - |
| Fisher et al., 2011 [43] (second) | 8 | sig ↑ | sig ↑ | - | - | sig ↑ | sig ↑ | ns ↑ | - |
| Fisher et al., 2011 [43] (third) | 8 | ns ↑ | ns ↑ | - | - | ns ↑ | sig ↑ | sig ↑ | - |
| Groussard et al., 2003 [44] | 8 | ns ↓ | ns ↓ | - | - | - | sig ↓ | ns | - |
| Hajizadeh et al., 2017 [45] (HICE) | 62 | - | - | - | - | - | - | - | - |
| Hajizadeh et al., 2017 [45] (HIIE) | 65 | - | - | - | - | - | - | - | - |
| Jammes et al., 2004 [46] | 19 | - | ns ↑ | - | - | - | - | - | ns ↓ |
| Jamurtas et al., 2018 [47] (HIIE) | 12 | - | ns ↑ | - | sig ↑ * | ns ↑ | - | - | - |
| Jamurtas et al., 2018 [47] (HICE) | 12 | - | ns ↑ | - | sig ↑ * | ns ↑ | - | - | - |
| Kyparos et al., 2007 [48] | 11 | - | sig ↑ | - | sig ↑ | sig ↑ | - | - | sig ↓ |
| Miyazaki et al., 2001 [49] (pre-training) | 9 | - | sig ↑ * | - | - | ns | ns ↑ | ns ↑ | - |
| Miyazaki et al., 2001 [49] (post-training) | 9 | - | sig ↑ * | - | - | ns | ns ↑ | ns ↓ | - |
| Parker et al., 2014 [50] (70% VO2max) | 14 | - | - | ns ↑ | sig ↑ * | - | - | - | - |
| Parker et al., 2014 [50] (85% VO2max) | 14 | - | - | ns ↑ | sig ↑ | - | - | - | - |
| Parker et al., 2014 [50] (100% VO2max) | 14 | - | - | ns ↑ | sig ↑ * | - | - | - | - |
| Parker et al., 2018 [51] (HIIE) | 8 | - | sig ↓ | - | - | ns ↑ | sig ↓ | - | - |
| Parker et al., 2018 [51] (SIE) | 8 | - | sig ↓ | - | - | ns ↑ | sig ↓ | - | - |
| Seifi-Skishahr et al., 2008 [52] | 10 | ns ↑ | - | - | - | - | - | - | - |
| Steinberg et al., 2007 [53] | 15 | ns ↑ | - | - | - | - | - | - | ns ↓ |
| Wadley et al., 2016 [54] (LV-HIIE) | 10 | - | - | - | ns ↓ | - | - | - | - |
| Wadley et al., 2016 [54] (HICE) | 10 | - | - | - | ns ↓ | - | - | - | - |
| Wiecek et al., 2018 [55] | 20 | - | - | - | - | ns ↑ | ns ↑ | ns ↓ | - |
Note: CAT, catalase; FFM, fat-free mass; GPX, glutathione peroxidase activity; GSH, glutathione; HICE, high-intensity continuous exercise; HIIE, high-intensity interval exercise; LV-HIIE, low-volume high-intensity interval exercise; MDA, malondialdehyde; ns, not significant; SIE, sprint interval exercise; sig, significant; SOD, superoxide dismutase; TAC, total antioxidant capacity; TBARS, thiobarbituric acid reactive substance; TBM, total body mass; VO2max, maximal oxygen uptake; *, significant difference between groups.